WVE logo

Wave Life Sciences (WVE) Selling, General & Administrative Expenses

Annual SGA

$51.29 M
+$779.00 K+1.54%

December 31, 2023

Summary

Performance

1-Year Change

+1.54%

3-Year Change

+20.66%

5-Year Change

+29.82%

15-Year Change

+90.15%

WVE SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.32%
WVE annual SGA is higher than 62.32% of companies in Healthcare sector

High & Low

All-time High

$51.29 M
WVE annual SGA is currently at an all-time high

3-Year Low

$46.10 M
WVE annual SGA is currently +11.25% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
WVE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 6, 2025
WVE next annual earnings announcement is scheduled for Mar 6, 2025

OtherWVEexpensesmetrics:

Annual Total Expenses

$181.30 M
WVE annual total expenses is $181.30 million

Annual Operating Expenses

$181.30 M
WVE annual total operating expenses is $181.30 million

Annual Cost Of Goods Sold

-
WVE annual cost of goods sold value is unknown

Annual Interest Expense

-
WVE annual interest expense value is unknown

Quarterly SGA

$15.04 M
+$746.00 K+5.22%

September 30, 2024

Summary

Performance

3-Month Change

+5.22%

1-Year Change

+10.08%

3-Year Change

+10.08%

5-Year Change

+10.08%

WVE Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.49%
WVE quarterly SGA is higher than 63.49% of companies in Healthcare sector

High & Low

All-time High

$15.04 M
WVE quarterly SGA is currently at an all-time high

3-Year Low

$11.61 M
WVE quarterly SGA is currently +29.57% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
WVE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 6, 2025
WVE next earnings announcement is scheduled for Mar 6, 2025

OtherWVEexpensesmetrics:

Quarterly Total Expenses

$56.24 M
WVE quarterly total expenses is $56.24 million

Quarterly Operating Expenses

$56.24 M
WVE quarterly total operating expenses is $56.24 million

Quarterly Cost Of Goods Sold

-
WVE quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
WVE quarterly interest expense value is unknown

TTM SGA

-$4.32 B
-$142.52 M-3.41%

September 30, 2024

Summary

Performance

3-Month Change

-8009.84%

1-Year Change

-8525.68%

3-Year Change

-8525.68%

5-Year Change

-8525.68%

WVE TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.95%
WVE TTM SGA is higher than 8.95% of companies in Healthcare sector

High & Low

All-time High

-$15.88 M

3-Year Low

-$4.32 B
WVE TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
WVE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 6, 2025
WVE next earnings announcement is scheduled for Mar 6, 2025

OtherWVEexpensesmetrics:

Annual Total Expenses

$181.30 M
WVE annual total expenses is $181.30 million

Annual Operating Expenses

$181.30 M
WVE annual total operating expenses is $181.30 million

TTM Cost Of Goods Sold

-
WVE TTM cost of goods sold value is unknown

TTM Interest Expense

-
WVE TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$51.29 M
WVE annual SGA is $51.29 million

Annual Operating Expenses

$181.30 M
WVE annual total operating expenses is $181.30 million

Annual Cost Of Goods Sold

-
WVE annual cost of goods sold value is unknown

WVE Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.5%+10.1%-8525.7%
3 y3 years+20.7%+10.1%-8525.7%
5 y5 years+29.8%+10.1%-8525.7%

WVE Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+11.3%at high+29.6%-40.9%at low
5 y5-yearat high+20.7%at high+56.9%-137.5%at low
alltimeall timeat high+3001.1%at high+1856.0%<-9999.0%at low

Wave Life Sciences Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$15.04 M(+5.2%)
$56.55 M(+3.5%)
Jun 2024
-
$14.30 M(+5.5%)
$54.64 M(+3.9%)
Mar 2024
-
$13.55 M(-0.8%)
$52.61 M(+2.6%)
Dec 2023
$51.29 M(+1.5%)
$13.66 M(+4.1%)
$51.29 M(-0.1%)
Sep 2023
-
$13.13 M(+7.0%)
$51.35 M(+3.0%)
Jun 2023
-
$12.27 M(+0.2%)
$49.83 M(-1.1%)
Mar 2023
-
$12.23 M(-10.8%)
$50.37 M(-0.3%)
Dec 2022
$50.51 M(+9.6%)
$13.72 M(+18.2%)
$50.51 M(+3.3%)
Sep 2022
-
$11.61 M(-9.3%)
$48.90 M(-2.7%)
Jun 2022
-
$12.81 M(+3.5%)
$50.24 M(+3.8%)
Mar 2022
-
$12.37 M(+2.1%)
$48.40 M(+5.0%)
Dec 2021
$46.10 M(+8.5%)
$12.11 M(-6.4%)
$46.10 M(+5.5%)
Sep 2021
-
$12.94 M(+18.0%)
$43.71 M(+8.3%)
Jun 2021
-
$10.97 M(+8.8%)
$40.36 M(+1.9%)
Mar 2021
-
$10.08 M(+3.7%)
$39.59 M(-6.9%)
Dec 2020
$42.51 M(-13.0%)
$9.72 M(+1.3%)
$42.51 M(-8.8%)
Sep 2020
-
$9.59 M(-6.0%)
$46.60 M(-5.9%)
Jun 2020
-
$10.21 M(-21.5%)
$49.53 M(-2.8%)
Mar 2020
-
$13.00 M(-5.9%)
$50.96 M(+4.3%)
Dec 2019
$48.87 M
$13.80 M(+10.2%)
$48.87 M(+2.2%)
Sep 2019
-
$12.52 M(+7.6%)
$47.82 M(+5.9%)
DateAnnualQuarterlyTTM
Jun 2019
-
$11.64 M(+6.8%)
$45.14 M(+6.4%)
Mar 2019
-
$10.90 M(-14.5%)
$42.41 M(+7.3%)
Dec 2018
$39.51 M(+46.5%)
$12.75 M(+29.5%)
$39.51 M(+17.4%)
Sep 2018
-
$9.85 M(+10.6%)
$33.64 M(+7.3%)
Jun 2018
-
$8.90 M(+11.3%)
$31.36 M(+7.7%)
Mar 2018
-
$8.00 M(+16.2%)
$29.13 M(+8.0%)
Dec 2017
$26.98 M(+68.7%)
$6.89 M(-9.0%)
$26.98 M(+6.7%)
Sep 2017
-
$7.57 M(+13.6%)
$25.27 M(+16.8%)
Jun 2017
-
$6.67 M(+14.0%)
$21.64 M(+16.2%)
Mar 2017
-
$5.85 M(+12.8%)
$18.63 M(+16.5%)
Dec 2016
$15.99 M(+53.9%)
$5.18 M(+31.6%)
$15.99 M(+9.9%)
Sep 2016
-
$3.94 M(+7.8%)
$14.55 M(+8.0%)
Jun 2016
-
$3.65 M(+13.6%)
$13.47 M(+14.9%)
Mar 2016
-
$3.22 M(-14.1%)
$11.72 M(+12.8%)
Dec 2015
$10.39 M(+246.5%)
$3.75 M(+31.1%)
$10.39 M(+34.9%)
Sep 2015
-
$2.86 M(+50.0%)
$7.70 M(+37.2%)
Jun 2015
-
$1.91 M(+1.1%)
$5.62 M(+51.3%)
Mar 2015
-
$1.88 M(+78.2%)
$3.71 M(+103.2%)
Dec 2014
$3.00 M(+81.3%)
$1.06 M(+37.5%)
$1.83 M(+137.5%)
Sep 2014
-
$769.00 K
$769.00 K
Dec 2013
$1.65 M
-
-

FAQ

  • What is Wave Life Sciences annual SGA?
  • What is the all time high annual SGA for Wave Life Sciences?
  • What is Wave Life Sciences annual SGA year-on-year change?
  • What is Wave Life Sciences quarterly SGA?
  • What is the all time high quarterly SGA for Wave Life Sciences?
  • What is Wave Life Sciences quarterly SGA year-on-year change?
  • What is Wave Life Sciences TTM SGA?
  • What is the all time high TTM SGA for Wave Life Sciences?
  • What is Wave Life Sciences TTM SGA year-on-year change?

What is Wave Life Sciences annual SGA?

The current annual SGA of WVE is $51.29 M

What is the all time high annual SGA for Wave Life Sciences?

Wave Life Sciences all-time high annual SGA is $51.29 M

What is Wave Life Sciences annual SGA year-on-year change?

Over the past year, WVE annual SGA has changed by +$779.00 K (+1.54%)

What is Wave Life Sciences quarterly SGA?

The current quarterly SGA of WVE is $15.04 M

What is the all time high quarterly SGA for Wave Life Sciences?

Wave Life Sciences all-time high quarterly SGA is $15.04 M

What is Wave Life Sciences quarterly SGA year-on-year change?

Over the past year, WVE quarterly SGA has changed by +$1.38 M (+10.08%)

What is Wave Life Sciences TTM SGA?

The current TTM SGA of WVE is -$4.32 B

What is the all time high TTM SGA for Wave Life Sciences?

Wave Life Sciences all-time high TTM SGA is -$15.88 M

What is Wave Life Sciences TTM SGA year-on-year change?

Over the past year, WVE TTM SGA has changed by -$4.37 B (-8525.68%)